Biohealersp. z o.o.

Retail sale via mail order houses or via Internet

KRS: NIP: REGON:

Overview

Status
Active
Registry date
2023-09-22
Share capital
10 000,00 PLN
Activity description

Biohealer offers a device using resonance technologies and more than 11,000 therapeutic programs. The programs are intended for conditions including asthma and respiratory diseases, mental disorders, Lyme disease, allergies, and heart and circulatory diseases; the device combines electromagnetic-field therapy with contact therapy.

Registered address
ul. Józefa Mehoffera 29/U2, 03-131 Warszawa, Poland
Website
biohealer.plWebsite active
Electronic delivery address
AE:PL-35152-88799-EITUB-22

Financials

The financial statement for 2025 has not yet been filed with the Financial Document Repository (past deadline).

Revenue history (in k)

Data and insights are generated automatically based on financial statements and may contain errors. This analysis is for informational purposes only and does not constitute an official assessment of the company's credibility or business advice.

Statistics

How the company ranks by revenue within its industry, region and across Poland in 2024.

Results vs industry

Revenue
This companyUSD 41.87kMedianUSD 77.32kAverageUSD 1.40m
Net profit
This companyUSD 22.57kMedianUSD 402.86AverageUSD 60.97k
Operating costs
This companyUSD 17.07kMedianUSD 76.39kAverageUSD 1.31m
Assets
This companyUSD 36.11kMedianUSD 43.35kAverageUSD 637.16k

Debt

No entries in the National Debtors Register (KRZ). No proceedings in KRZ

Public aid

No public aid cases recorded in the last 10 years.

Tenders

No recorded participation in tenders.

Authorized Representatives

Emil Tomasz Świeca – President of the Management Board

Manner of representation

In the case of a one-person management board, the member of the management board makes declarations on behalf of the company. In the case of a management board consisting of two or more persons, joint action by two members of the management board or by one member of the management board jointly with a commercial proxy is required to make declarations on behalf of the company.

Ownership

OwnerSharesShare valueStake
Anna Świeca (38)
15$405.1915%
Emil Tomasz Świeca (42)
85$2,296.0685%

Emil Tomasz Świeca and Anna Świeca hold a combined 100% – the ownership structure indicates family control.

Beneficial owners

Person

Competitors

Name
Demalosp. z o.o.
Medar Technika Medycznasp. z o.o.
MBS Medicalsp. z o.o.
Neoregensp. z o.o.
Atmis Suppliessp. z o.o.
Aiiasp. z o.o.
Medicalsolutions24sp. z o.o.
M-Fizjosp. z o.o.
Medibosp. z o.o. + limited partnership
Naturalnie na Zdrowiesp. z o.o.

FAQ

Last updated: 2026-04-26